CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Resilience Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has an Asset Resilience Ratio of 6.14% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of CSPC Innovation Pharmaceutical Co Ltd Cl for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. See CSPC Innovation Pharmaceutical Co Ltd Cl (300765) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down CSPC Innovation Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CSPC Innovation Pharmaceutical Co Ltd Cl market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥385.39 Million | 6.14% |
| Total Liquid Assets | CN¥385.39 Million | 6.14% |
Asset Resilience Insights
- Limited Liquidity: CSPC Innovation Pharmaceutical Co Ltd Class A maintains only 6.14% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CSPC Innovation Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio
Compare CSPC Innovation Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
General Mills Inc
NYSE:GIS |
Packaged Foods | 2.10% |
|
Sam Yang Foods
KO:003230 |
Packaged Foods | 2.26% |
|
Cisarua Mountain Dairy Tbk PT
JK:CMRY |
Packaged Foods | 26.56% |
|
Nongshim
KO:004370 |
Packaged Foods | 25.27% |
|
Zhejiang Huatong Meat Products Co Ltd
SHE:002840 |
Packaged Foods | 3.78% |
|
V V Food & Beverage Co Ltd
SHG:600300 |
Packaged Foods | 0.01% |
|
Xiangpiaopiao Food Co Ltd
SHG:603711 |
Packaged Foods | 8.98% |
|
Zhongjing Food Co. Ltd.
SHE:300908 |
Packaged Foods | 0.00% |
Annual Asset Resilience Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2019–2025)
The table below shows the annual Asset Resilience Ratio data for CSPC Innovation Pharmaceutical Co Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.14% | CN¥385.39 Million ≈ $56.39 Million |
CN¥6.28 Billion ≈ $918.42 Million |
-1.67pp |
| 2024-12-31 | 7.81% | CN¥470.09 Million ≈ $68.79 Million |
CN¥6.02 Billion ≈ $881.22 Million |
-3.25pp |
| 2021-12-31 | 11.06% | CN¥413.59 Million ≈ $60.52 Million |
CN¥3.74 Billion ≈ $547.46 Million |
+0.17pp |
| 2020-12-31 | 10.89% | CN¥321.94 Million ≈ $47.11 Million |
CN¥2.96 Billion ≈ $432.64 Million |
-22.77pp |
| 2019-12-31 | 33.66% | CN¥960.09 Million ≈ $140.49 Million |
CN¥2.85 Billion ≈ $417.39 Million |
-- |
About CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more